Indian drugmaker to produce 200 million doses of Russia’s Sputnik V ...Middle East

Daily Sun - News
Indian drugmaker to produce 200 million doses of Russia’s Sputnik V
MOSCOW: The developer of Russia’s Sputnik V coronavirus vaccine said Friday it had signed a partnership with an India-based drugmaker for the production of 200 million doses of the two-dose jab.The Russian Direct Investment Fund (RDIF), which backed the development of Sputnik V, said in a statement it had partnered with Stelis Biopharma “to produce and supply a minimum of 200 million doses of the Russian Sputnik V vaccine”.Stelis Biopharma is expected to be able to start supplying the vaccine from the second half of the year.RDIF, added that Stelis — the biopharma unit of global pharmaceutical company Strides — will work with the Russian wealth fund to provide supplies “beyond the initial ag

Hence then, the article about indian drugmaker to produce 200 million doses of russia s sputnik v was published today ( ) and is available on Daily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Indian drugmaker to produce 200 million doses of Russia’s Sputnik V )

Apple Storegoogle play

Last updated :

Also on site :